Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -4.10
- Piotroski Score 1.00
- Grade Buy
- Symbol (LIFE)
- Company aTyr Pharma, Inc.
- Price $1.90
- Changes Percentage (2.7%)
- Change $0.05
- Day Low $1.82
- Day High $1.95
- Year High $2.45
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. It is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. The company was incorporated in 2005 and is headquartered in San Diego, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $11.00
- High Stock Price Target $11.00
- Low Stock Price Target $11.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.88
- Trailing P/E Ratio -2.16
- Forward P/E Ratio -2.16
- P/E Growth -2.16
- Net Income $-50,389,000
Income Statement
Quarterly
Annual
Latest News of LIFE
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Moving internationally taught me how to declutter. Now, my husband and I live a minimalist lifestyle.
Through multiple moves between Canada and the UK, the author mastered decluttering. They realized the accumulation of unnecessary items and embraced a minimalist lifestyle, focusing on practical belon...
By Business Insider | 14 hours ago -
The play that changed my life: Janet Suzman on staging Othello in apartheid South Africa
In 1987, a production of Shakespeare's Othello at Johannesburg's Market Theatre caused a stir in apartheid-era South Africa. Directed by a close associate of the theatre, the play challenged racial ta...
By The Guardian | 15 hours ago -
Ten Lifestyle Group (LON:TENG) investors are sitting on a loss of 54% if they invested five years ago
Intelligent long-term investing is preferred, but even long-term investors face losses. Ten Lifestyle Group's share price fell 54% over 5 years and 44% in the last year. Company's revenue increased by...
By Yahoo! Finance | 17 hours ago
